In this study, we discovered a novel anti-tumor mechanism of maspin to repress androgen receptor (AR) transcription, which augmented the treatment efficacy of AR antagonist enzalutamide in prostate cancer. This evidence concerns the gene SERPINB5 and prostate cancer.